• Mashup Score: 9
    Individual response - 1 year(s) ago

    I can see how important patient/treatment qualitative interactions could be missed as a result of poor RCT design (e.g., inappropriate “lumping” of patients in disparate clinical states into a single trial). Failure to do adequate preparatory study to optimize disease definition, trial inclusion criteria, and measurement tools would be analogous to a drug company skipping preclinical or early phase clinical studies and jumping to phase III- the chance of success would be very low (see below). I…

    Tweet Tweets with this article
    • RT @f2harrell: Great discussion at https://t.co/nvDWNyxfyR . "the counterfactual approach requires a faithful belief in metaphysical obje…